Physician profile
Rodrigo E Morales
NPI 1780609867
$25,410.42
in general payments reported to CMS, 2019-2025
46 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,061 · 2020: $5,265 · 2021: $1,625 · 2022: $2,974 · 2023: $2,095 · 2024: $2,051 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,195 · Travel and Lodging: $1,625 · Education: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,194.91 |
| Travel and Lodging | $1,625.42 |
| Education | $664.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $11,341.05 | 2019-2024 | Yupelri |
| Olympus Corporation of The Americas | $2,979.72 | 2022-2025 | Spiration Valve System |
| Harmony Biosciences LLC | $1,644.08 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $1,031.16 | 2019-2025 | Xywav |
| Insmed, INC. | $957.22 | 2019-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $924.64 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $794.58 | 2020-2025 | Airsupra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $582.36 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $526.10 | 2019-2025 | Opsumit, Uptravi |
| Grifols USA, LLC | $457.45 | 2020-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $408.58 | 2019-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $329.29 | 2019-2025 | |
| Axsome Therapeutics, INC. | $312.69 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $284.57 | 2023-2025 | Lumryz |
| Baxter Healthcare | $254.94 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $221.42 | 2024-2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $220.65 | 2023-2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $219.44 | 2024-2025 | |
| Viatris Specialty LLC | $175.31 | 2025 | Yupelri |
| Verona Pharma, INC. | $128.58 | 2025 | Ohtuvayre |
| Philips North America LLC | $128.56 | 2020-2024 | (Ak6) Vest Therapy |
| Amgen INC. | $124.44 | 2023 | Tezspire |
| Vapotherm INC | $115.21 | 2019-2021 | |
| Inspire Medical Systems, INC. | $114.13 | 2023-2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $112.83 | 2024-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $104.19 | 2021-2023 | Glassia |
| Advanced Respiratory, INC | $101.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Merck Sharp & Dohme LLC | $75.03 | 2020-2025 | Winrevair |
| Janssen Pharmaceuticals, INC | $73.20 | 2020-2022 | |
| Optinose US, INC. | $70.96 | 2020-2022 | |
| Vifor Pharma, INC. | $70.87 | 2024 | Zemaira |
| Csl Behring | $57.77 | 2019-2020 | |
| Pfizer INC. | $50.46 | 2022-2023 | |
| Pulmonx Corporation | $49.45 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Tactile Systems Technology INC | $43.96 | 2024 | Entre Plus, Flexitouch Plus |
| Hikma Pharmaceuticals USA | $43.78 | 2023-2024 | Ryaltris |
| Lilly USA, LLC | $42.72 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $21.58 | 2024 | Quviviq |
| Eisai INC. | $20.38 | 2020 | |
| Circassia INC. | $18.70 | 2019 | |
| Abbvie INC. | $17.20 | 2020 | |
| Veran Medical Technologies, INC. | $15.86 | 2019 | |
| Gilead Sciences, INC. | $15.28 | 2022 | |
| Resmed Corp | $15.27 | 2023 | |
| Electromed, INC. | $14.09 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodrigo Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.